KRAS and hepatocellular carcinoma: Another well-documented example is that PBL-derived T cells genetically engineered with a high-affinity, HLA-A2-restricted, hepatitis C virus (HCV) NS3-reactive TCR can recognize naturally processed antigen and elicit CD8-independent recognition of both peptide-loaded targets and HCV+ human hepatocellular carcinoma cell lines.